Risk factors for noninvasive ventilation failure in patients with acute cardiogenic pulmonary edema: A prospective, observational cohort study

J Crit Care. 2017 Jun:39:238-247. doi: 10.1016/j.jcrc.2017.01.001. Epub 2017 Jan 6.

Abstract

Purpose: We identified risk factors for noninvasive ventilation (NIV) failure in patients with acute cardiogenic pulmonary edema (ACPE).

Materials and methods: We conducted an observational cohort study over a 3-year period in a 28-bed emergency intensive care unit (EICU) and prospectively included all consecutive patients in whom NIV was attempted as initial ventilatory support for ACPE. The primary outcome variables were NIV failure rate and risk factors for NIV failure.

Results: Among the 118 patients in the study, NIV failed for 44 (37.3%) patients. Risk factors for NIV failure were Killip class IV (odds ratio [OR], 28.56; 95% confidence interval [CI], 2.17-375.73; p=0.011), left ventricular ejection fraction (LVEF) <30% (OR, 9.54; 95% CI, 1.01-90.55; p=0.050) and B-type natriuretic peptide (BNP) ≥3350pg/mL (OR, 39.63; 95% CI, 3.92-400.79; p=0.002) at baseline, and fluid balance ≥400mL within 24h after ACPE (OR, 13.19; 95% CI, 1.18-147.70; p=0.036).

Conclusions: NIV failure occurred in 37.3% of ACPE patients in a real-world EICU. When patients had Killip class IV, a lower LVEF, a higher BNP, and a more positive fluid balance within 24h after ACPE, the risk of failure was higher. TRIAL REGISTRATION CLINICALTRIALS.

Gov identifier: NCT02653365.

Keywords: Acute cardiogenic pulmonary edema; Endotracheal intubation; Noninvasive ventilation; Risk factor.

Publication types

  • Observational Study

MeSH terms

  • Acute Disease
  • Aged
  • Data Collection
  • Female
  • Hemodynamics
  • Humans
  • Intensive Care Units
  • Intubation, Intratracheal
  • Male
  • Middle Aged
  • Noninvasive Ventilation / adverse effects*
  • Odds Ratio
  • Prospective Studies
  • Pulmonary Edema / complications*
  • Pulmonary Edema / therapy*
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Associated data

  • ClinicalTrials.gov/NCT02653365